Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_assertion type Assertion NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_head.
- NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_assertion description "[In a registry-based group of 525 recent-onset IDDM patients <40 years old we investigated the possible interactions of a CTLA-4 gene A-to-G transition polymorphism with age at clinical disease onset and with the presence or absence of established genetic (HLA-DQ, INS VNTR) and immune disease markers (autoantibodies against islet cell cytoplasm (ICA); insulin (IAA); glutamate decarboxylase (GAD65-Ab); IA-2 protein tyrosine phosphatase (IA-2-Ab)) determined within the first week of insulin treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_provenance.
- NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_assertion evidence source_evidence_literature NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_provenance.
- NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_assertion SIO_000772 9353155 NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_provenance.
- NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_assertion wasDerivedFrom befree-20150227 NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_provenance.
- NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_assertion wasGeneratedBy ECO_0000203 NP429108.RAUDycyatkQLAD5J8hf2CjkRxFv7VbzgkBZjs_XHRuG5U130_provenance.